Lnc000048 regulates the expression of MAP2K2 (mitogen-activated protein kinase 2) by inhibiting the demethylation activity of LSD1 to promote the phosphorylation level of ERK and ultimately affects the atherosclerosis process in mice.103. Here, KDM1A is linked to atherosclerosis.